Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
758
-
Total 13F shares, excl. options
-
57,604,943
-
Shares change
-
+8,544,557
-
Total reported value, excl. options
-
$7,875,097,725
-
Value change
-
+$1,185,874,028
-
Put/Call ratio
-
128%
-
Number of buys
-
410
-
Number of sells
-
-251
-
Price
-
$136.69
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2020
861 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q2 2020.
ISHARES TR - ISHARES BIOTECH (IBB) has 758 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57,604,943 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (12,517,595 shares), GOLDMAN SACHS GROUP INC (6,444,162 shares), MORGAN STANLEY (5,248,349 shares), JPMORGAN CHASE & CO (2,994,776 shares), BNP PARIBAS ARBITRAGE, SA (2,836,707 shares), BARCLAYS PLC (2,602,369 shares), UBS Group AG (2,366,203 shares), CHURCHILL MANAGEMENT Corp (1,603,839 shares), CITIGROUP INC (1,283,052 shares), and ROYAL BANK OF CANADA (1,237,768 shares).
This table shows the top 758 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.